Glucocorticoid synthesis-related genes: HSD11B1 and HSD11B2 in hypertensive disorders in pregnancy

References

• Procopciuc LM, Hazi GM, Caracostea G, et al. Correlation between the TSHRc-Asp727Glu polymorphism and plasma thyroid stimulating hormone levels in Romanian preeclamptic women. Gynecol Endocrinol 2011;27:225–31
   PubMed Web of Science ®Google Scholar
• Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000;91:256–60
   PubMed Web of Science ®Google Scholar
• Cheng MH, Wang PH. Placentation abnormalities in the pathophysiology of preeclampsia. Expert Rev Mol Diagn 2009;9:37–49
   PubMed Web of Science ®Google Scholar
• Pepe GJ, Burch MG, Albrecht ED. Expression of the 11beta-hydroxysteroid dehydrogenase types 1 and 2 proteins in human and baboon placental syncytiotrophoblast. Placenta 1999;20:575–82
   PubMed Web of Science ®Google Scholar
• Draper N, Walker EA, Bujalska IJ, et al. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 2003;34:434–9
   PubMed Web of Science ®Google Scholar
• Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166–70
   PubMed Web of Science ®Google Scholar
• Mukherjee S, James JL, Thilaganathan B, et al. Elevated glucocorticoid metabolism in placental tissue from first trimester pregnancies at increased risk of pre-eclampsia. Placenta 2011;32:687–93
   PubMed Web of Science ®Google Scholar
• Alfaidy N, Gupta S, DeMarco C, et al. Oxygen regulation of placental 11 beta-hydroxysteroid dehydrogenase 2: physiological and pathological implications. J Clin Endocrinol Metab 2002;87:4797–805
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
   PubMed Web of Science ®Google Scholar
• Shimodaira M, Nakayama T, Sato N, et al. Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure. Eur J Endocrinol 2010;163:671–80
   PubMed Web of Science ®Google Scholar
• Ness RB, Markovic N, Bass D, et al. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003;102:1366–71
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Inaba S, Miyamori I. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension. Hypertension 1999;33:1179–84
   PubMed Web of Science ®Google Scholar
• Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 2003;88:2384–92
   PubMed Web of Science ®Google Scholar
• Chamarthi B, Kolatkar NS, Hunt SC, et al. Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension. J Clin Endocrinol Metab 2007;92:1340–6
   PubMed Web of Science ®Google Scholar
• Shimodaira M, Nakayama T, Sato I, et al. Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy. Endocrine 2012;42:700–7
   PubMed Web of Science ®Google Scholar
• Coto E, Tavira B, Marin R, et al. Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy. Biochem Biophys Res Commun 2010;397:576–9
   PubMed Web of Science ®Google Scholar
• Tomlinson JW, Walker EA, Bujalska IJ, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004;25:831–66
   PubMed Web of Science ®Google Scholar
• Morales MA, Carvajal CA, Ortiz E, et al. Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension. Rev Med Chil 2008;136:701–10
   PubMed Web of Science ®Google Scholar
• Franks PW, Knowler WC, Nair S, et al. Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension 2004;44:681–8
   PubMed Web of Science ®Google Scholar
• Bruley C, Lyons V, Worsley AG, et al. A novel promoter for the 11beta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent. Endocrinology 2006;147:2879–85
   PubMed Web of Science ®Google Scholar
• Ku YH, Koo BK, Kwak SH, et al. Regulatory effect of common promoter polymorphisms on the expression of the 11beta-hydroxysteroid dehydrogenase type 1 gene. Horm Res 2009;72:25–32
   PubMedGoogle Scholar
• Malavasi EL, Kelly V, Nath N, et al. Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels. Endocrinology 2010;151:195–202
   PubMed Web of Science ®Google Scholar
• Alfaidy N, Li W, MacIntosh T, et al. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. J Clin Endocrinol Metab 2003;88:5033–8
   PubMed Web of Science ®Google Scholar
• Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 1988;82:340–9
   PubMed Web of Science ®Google Scholar
• Li A, Tedde R, Krozowski ZS, et al. Molecular basis for hypertension in the “type II variant” of apparent mineralocorticoid excess. Am J Hum Genet 1998;63:370–9
   PubMed Web of Science ®Google Scholar
• McCalla CO, Nacharaju VL, Muneyyirci-Delale O, et al. Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies. Steroids 1998;63:511–15
   PubMed Web of Science ®Google Scholar
• Alfaidy N, Blot-Chabaud M, Robic D, et al. Characteristics and regulation of 11 beta-hydroxysteroid dehydrogenase of proximal and distal nephron. Biochim Biophys Acta 1995;1243:461–8
   PubMed Web of Science ®Google Scholar
• Masuzaki H, Yamamoto H, Kenyon CJ, et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003;112:83–90
   PubMed Web of Science ®Google Scholar